Skip to main content
    D

    Dentsply Sirona Inc (XRAY)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $8.95
    -0.22 (-2.35%)

    Market Cap: $1.83B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Dentsply Sirona Inc (XRAY) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Dentsply Sirona (XRAY) to earn $1.33 per share in the fiscal year ending Dec 31, 2026, on revenue of $3.51B. Of 17 analysts, 4 rate the stock Buy or Strong Buy, 12 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 5 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 17 ratings average 2.76, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 24% of the ratings.

    RatingAnalystsShare
    Strong Buy211.8%
    Buy211.8%
    Hold1270.6%
    Sell00.0%
    Strong Sell15.9%
    Consensus
    Hold
    Total analysts
    17

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus falls 6.0% and revenue estimates rise 0.3%.

    Fiscal year ending Dec 31, 2026
    $1.33
    EPS consensus, revenue $3.51B
    Fiscal year ending Dec 31, 2027
    $1.25
    EPS consensus, revenue $3.52B
    Next report
    Feb 24, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$1.33$1.22 to $1.4616$3.51B$3.48B to $3.55B15
    Dec 31, 2027$1.25$1.08 to $1.5517$3.52B$3.43B to $3.62B16

    Quarterly Estimates

    The EPS consensus falls from $0.31 for the quarter ending Dec 31, 2026 to $0.27 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.31$0.16 to $0.4918$909.19M$862.78M to $957.60M16
    Mar 31, 2027$0.27$0.23 to $0.3111$860.80M$832.00M to $891.20M7

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 0 upward and 13 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202605
    Fiscal year ending Dec 31, 202706
    Quarter ending Mar 31, 202702

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 11.3% from $1.50.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$1.33$1.49$1.49$1.50$1.50-11.5%
    Fiscal year ending Dec 31, 2027$1.25$1.48$1.50$1.52$1.52-17.8%
    Quarter ending Mar 31, 2027$0.27$0.30$0.30$0.30$0.31-12.9%

    Frequently Asked Questions About XRAY

    What is the XRAY stock forecast?

    Consensus analyst estimates put Dentsply Sirona's EPS at $1.33 for the fiscal year ending Dec 31, 2026, on revenue of $3.51B. The consensus rating from 17 analysts is Hold.

    How do analysts rate XRAY stock?

    Of 17 analysts covering Dentsply Sirona, 2 rate it Strong Buy, 2 Buy, 12 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from XRAY next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $1.33, with estimates from $1.22 to $1.46 from 16 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.25, with estimates from $1.08 to $1.55 from 17 analysts.

    What revenue do analysts expect from Dentsply Sirona next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $3.51B, with estimates from $3.48B to $3.55B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.52B, with estimates from $3.43B to $3.62B.

    How many analysts cover XRAY?

    17 analysts rate Dentsply Sirona stock, and 16 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.